Comparing the efficacy of low-level light laser therapy plus minoxidil 5% and minoxidil 5% alone in the treatment of androgenetic alopecia

Vice Chancellor for Research, Isfahan University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新: 2018年2月22日

适应症

试验速览

暂无简介。

•consent to participate; absence of other causes of hair loss; types 1-4 on Fitzpatrick scale; stages 3-6 on Norwood Hamilton Scale (for male patter baldness); stages 2-3 on the Ludwig Scale for hair loss in women; no history of finasteride, antiandrogens (e.g. cyproterone, spironolactone, ketoconazole, and flutamide), topical estrogen, progesterone, tamoxifen, anabolic steroids, drugs potentially associated with hypertrichosis (e.g. cyclosporine, diazoxide, phenytoin, oral glucocorticoids, lithium, and phenothiazine during the three-month period before the study.
•Exclusion criteria: using the above-mentioned medicines during the study; lack of adherence to treatment protocol; hair transplant; any medical conditions leading to hair loss (e.g. HIV/AIDS, connective tissue disease, and inflammatory bowel disease); development of endocrinopathies such as PCO, ovarian and adrenal gland tumors, and hypothyroidism.

发起方

Vice Chancellor for Research, Isfahan University of Medical Sciences